Vildagliptine/Metformine Krka 50 mg - 850 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vildagliptine/metformine krka 50 mg - 850 mg filmtablette

krka, d.d. novo mesto - vildagliptin; metformin hydrochlorid - filmtablette - 50 mg - 850 mg - vildagliptin 50 mg; metformin hydrochlorid 850 mg - metformin and vildagliptin

Vildagliptine/Metformine Krka 50 mg - 1000 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vildagliptine/metformine krka 50 mg - 1000 mg filmtablette

krka, d.d. novo mesto - vildagliptin; metformin hydrochlorid - filmtablette - 50 mg - 1000 mg - vildagliptin 50 mg; metformin hydrochlorid 1000 mg - metformin and vildagliptin

Galvus Europäische Union - Deutsch - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Europäische Union - Deutsch - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).

Xiliarx Europäische Union - Deutsch - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).